25-28 May 2016 Montpellier
0-VWF | Structure and mechanics of von Willebrand factor are regulated by pH-dependent interactions in dimeric subunits | Jochen P. Mller | Received |
1-LUP | Inverted Erythrocyte Membranes as a Novel Model for Studying the Antiphospholipid Syndrome | Saartje Bloemen | Received |
1-WOR | Absence of Pre-Operative VWF Workup is Associated with Increased Intraoperative Bleeding during Wilms Tumor Resection | Shiu-Ki Hui | Received |
1-GEN | Diagnosis of Inherited Platelet Disorders by a Panel-Based Next Generation Sequencing Approach | Harald Schulze | Received |
1-BR | Microfluidic Platform for Automated Endothelial Cell Culture Enabling Real Time Visualisation of Blood Cell Function under Flow | Crispin Szydzik | Received |
1-HEM | The anti-cancer action of high versus low doses aspirin | Annachiara Mitrugno | Received |
1-VWF | Blood Outgrowth Endothelial Cells from Type 3 von Willebrand Disease Patients Display Abnormal Angiogenesis | Soundarya Selvam | Received |
1-DIC | Porcine Model of Methicillin-resistant Staphylococcus Aureus (MRSA) Sepsis-induced Disseminated Intravascular Coagulation (DIC) | Trung Nguyen | Received |
1-PLA | HIF-2a Downregulates Tissue Factor Pathway inhibitor Expression in Breast Cancer | Xue Yan Cui | Received |
1-FIB | Hyaluronic Acid Decreases the Mechanical Stability, but Increases the Lytic Resistance of Fibrin | Keasimir Kolev | Received |
1-FVIII | INSIGHT Case-Control Study: High FVIII Concentrate Dose and Surgery Are Associated with Increased Inhibitor Risk in Nonsevere Hemophilia A Patients | Karin Fijnvandraat | Received |
1-FXI | Novel Mechanisms Regulating Factor XI Plasma Levels | Maria Sabater-Lleal | Received |
1-PRE | Transient Impact of Treatment Exposures and One-year Incidence of Thrombosis in Multiple Myeloma: A Case-time-Control Analysis | Joshua Brown | Received |
1-WOM | Phenotype of Congenital Factor XIII Deficiency in Women: Report of the French Cohort | Christophe Martinaud | Received |
2-FXIII | Structure and Function Consequences of a Novel Missense Mutation in FGB Gene (Bbeta Gly272Arg/p.Gly302Arg) Resulting in Afibrinogenemia | German Detarsio | Received |
2-GEN02 | Design and Application of a Twenty-Three-Gene Panel by Next-Generation Sequencing for Inherited Coagulation Bleeding Disorders | JOSE MARIA BASTIDA | Received |
2-PP | Defects in TRPM7 Channel Function Deregulate Thrombopoiesis through Altered Cellular Mg2 Homeostasis and Cytoskeletal Architecture | Simon Stritt | Received |
2-LUP | Pravastatin Ameliorates Preeclampsia and/or Severe IUGR in 13 Women with Refractory Obstetric Antiphospholipid Syndrome (APS) | Eleftheria Lefkou | Received |
2-WOR | High Variation of Peri-Operative Bridging Use in Real-World Practice: Results from a Clinician Survey | Geoffrey Barnes | Received |
2-VWF | Inhibition of vWF Secretion with Novel Galpha 12 N-terminal alpha-SNAP Binding Domain Peptide Increases Survival in Septic Mice | Luiza Rusu | Received |
2-WOM | Abnormal Platelet GPIba and Pregnancy Outcome: An Exploratory Study | Maha Othman | Received |
2-HEM | Platelets Upregulate c-MYC Oncoprotein in Pancreatic Cancer Cells: Potential Mechanism of Platelet-Driven Neoplastic Proliferation | Annachiara Mitrugno | Received |
2-PED | Characterization of Laboratory Coagulation Parameters and Risk Factors for Intraventricular Hemorrhage (IVH) in Extremely Premature Neonates | Jonathan Roberts | Received |
2-PLA | Antithrombin Resistance Caused by c.1787GA Mutation in Prothrombin Gene: Rare but Strong Inherited Thrombophilia | Predrag Miljic | Received |
2-BR | Occlusive Thrombus Growth at High Shear Rates: Comparison of Whole Blood and Platelet Rich Plasma at Constant Pressure | Shunichi Kobayashi | Received |
3-LUP | Mixing Test Specific Cut-off is More Sensitive at Detecting in vitro Lupus Anticoagulant Inhibition than the Index of Circulating Anticoagulant with Multiple APTT and dRVVT Reagents | Osamu Kumano | Received |
3-VAS | CD146 Deficiency Leads to Accelerated Atherosclerosis in Mice through Upregulation of RANTES | Marie Nollet | Received |
3-FXIII | Visual Quantification of Fibrin Network Density | Joke Konings | Received |
3-AMC | Time-Dependent Decay of mRNA, Ribosomal RNA and Translation Activity in Platelets | Catherine Angénieux | Received |
3-BR | Shear-Dependent Red Blood Cell and Platelet Adhesion in Sickle Cell Disease | Erdem Kucukal | Received |
3-VWF | Role of the Arterial Pulsatility in the Modulation of von Willebrand Factor Multimerisation in an Animal Model of Continuous-Flow Left Ventricular Assist Support | Antoine Rauch | Received |
3-FVIII | FVIII-LRP1 Interaction affinity is Biased by FVIII Concentration | Michael Dockal | Received |
3-PP | Clinical and Pathogenetic Characterization of ETV6-Related Thrombocytopenia (ETV6-RT), an Inherited Thrombocytopenia (IT) Predisposing to Childhood Acute Lymphoblastic Leukemia (ALL) | Patrizia Noris | Received |
3-DIC | Laboratory Tests as Clues to Understand the Etiopathogenesis of Hemostatic Disturbances, Acute Kidney Injury and Mild Intravascular Hemolysis in Bothrops Envenomation | Marcelo Santoro | Received |
3-PLA | TFPI Levels and Correlation with Coagulation Parameters Based on Longitudinal Observations in Healthy Subjects | Jadranka Koehn | Received |
3-WOM | A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia | Leslie Skeith | Received |
3-PED | Increased Incidence and High Recurrence Rate of Venous Thromboembolism in Pediatric Oncology Patients in One Single Center over 25 Years | Irene Klaassen | Received |
4-FXI | Assessment of Small Molecular Weight Inhibitors of the Contact Pathway | Charlotte Bouckaert | Received |
4-FVIII | Variation in Baseline Factor VIII Concentration in Mild and Moderate Hemophilia A Patients Carrying the Same F8 Mutation | Janneke Loomans | Received |
4-DIC | Tissue Factor Initiated Thrombin Generation in Trauma Patient Plasma | Saulius Butenas | Received |
4-LUP | Evaluation of a New Formulation Dilute Russells Viper Venom Time for Detection of Lupus Anticoagulants | Gary Moore | Received |
4-CA | Genetic Dosing Algorithm Underestimates the Warfarin Dose Requirement among Patients Having Severe Thrombosis and/or Thrombophilia | Tuukka Helin | Received |
4-PED | Central Venous Catheters and Pediatric Thromboembolism, a Report from the Childrens Hospital Acquired Thrombosis (CHAT) Registry | Julie Jaffray | Received |
4-VAS | SGK1 Deficiency Protects from Neointima Formation via Reduction of Ca2-Dependent VSMC Migration | Sascha Geue | Received |
4-BR | Clot-Bound Thrombin under Venous Flow Conditions | Laura Haynes | Received |
4-PLA | Diagnostic Issues in Antithrombin, Protein C and Protein S Deficiency in the Hungarian Population: Experience of a Large Thrombosis Laboratory | Zsuzsanna Bereczky | Received |
4-AMC | Platelets Promote MMP-Dependent Plaque Destabilization Locally at the Site of Vascular Injury | Tom Mastenbroek | Received |
4-FXIII | Development and Evaluation of Total and Free Factor XIII-B Subunit ELISA Methods | Éva Katona | Received |
4-FIB | Recombinant Human ADAMTS13: First-in-Human Study Evaluating Pharmacokinetics, Safety and Tolerability in hTTP Patients | Jennifer Doralt | Received |
4-VWF | Possible Role of Protein Disulfide Isomerase PDIA in Mechanisms of von Willebrand Disease Type 3 | Maria A. Brehm | Received |
5-BR | Hemorheologic Bases for Thrombosis in Some Oncohematologic Diseases | Irina Kolesnikova | Received |
5-WOM | Hematologic Alterations in Patients Undergoing Controlled Ovarian Stimulation for in vitro Fertilization: A Prospective Observational Pilot Study | Maria T DeSancho | Received |
5-FXIII | FXIII Activity and Antigen during Pregancy | Carsten Detering | Received |
5-PRE | Acute Isolated Superficial-Vein Thrombosis is Associated with Substantial Comorbidity and History of Venous Thromboembolic Complications | Marie-Antoinette Sevestre | Received |
5-CA | Impact of Apixaban on the Dilute Russells Viper Venom Time: An Ex-vivo Study | Anne-Laure Sennesael | Received |
5-LUP | Lupus Patients with IgM Antiphospholipid Antibodies Are at Risk of Thrombocytopenia and Haemolytic Anemia: Pooled Results from Five Systematic Reviews and Meta-Analyses | Stéphane Zuily | Received |
5-VAS | Lysine-Rich Histones Induce Weibel-Palade Body Exocytosis through a Calcium, Caspase and Charge-Dependent Mechanism | Alison Michels | Received |
5-PP | Three-Dimensional Electron Microscopy Reveals New Details for Platelet Granule Exocytosis: Granule-to-Granule Versus Granule-to-Platelet Membrane Fusion | Anita Eckly | Received |
5-PLA | The Performance of Thrombin Generation Assays is Compromised at Reduced Plasma Levels of Antithrombin III | Michael Dockal | Received |
5-PED | Six Weeks Versus Three Months of Anticoagulant Treatment for Paediatric Central Venous Catheter-Related Venous Thromboembolism | Fiona Newall | Received |
5-FXI | Copurification of Polyphosphate with Nucleic Acids May Contribute to the Procoagulant Activity of DNA and RNA | Stephanie Smith | Received |
6-FXIII | Thromboelastography (TEG) and Thrombin Generation Assay (TGA) in Congenital Afibrinogenemia | VIRIDIANA CANO GARCIA | Received |
6-DIC | Coagulopathy Assessment in Severe Sepsis and Septic Shock Patients. An Observational Pilot Study | Ecaterina Scarlatescu | Received |
6-PED | Circumcision in Children with Haemophilia | HANDE KIZILOCAK | Received |
6-FXI | Correlation between the Thrombogenic Factor XIa and the Thrombus Score in the Venous Stasis Rabbit Model | CHARLES-EDOUARD LAURENT | Received |
6-AMC | Lack of Endothelial Nitric Oxide Synthase (eNOS) Induces a Pro-Thrombotic Phenotype in Mice | Stefania momi | Received |
6-LUP | Use of a Lupus Anticoagulant-Resistant Routine APTT Reagent as a Convenient Confirmatory Test | Osamu Kumano | Received |
6-BR | Thrombus Structure Change under Various Shear Rate, Using a Novel Microfluidic Device | Hideo Hirakata | Received |
6-PP | Blood Coagulation Factors Bound to Procoagulant Platelets Are Concentrated in Their Cap Structures to Promote Clotting | Nadezhda Podoplelova | Received |
6-WOM | Sociodemographic Characteristics of Women with Postpartum Hemorrhage: A Nationwide Inpatient Sample (NIS)-Based Analysis | Ariela Marshall | Received |
7-CA | Optimizing Therapy for Vitamin K Antagonist Induced Major Hemorrhage: A Systematic Review | Samuel Abegunde | Received |
7-HEM | Thromboembolic Events (TE) in Patients with Metastatic Non Small Cell lung Cancer (NSCLC) Treated with Platinum-based Chemotherapy | Victoria Eugenia Castellon Rubio | Received |
7-DIC | Coagulation Changes in Porcine Model of Sepsis Induced by Methicillin-Resistant Staphylococcus aureus (MRSA) Inoculation: Correlation between ROTEM and Routine Laboratory Tests | Jun Teruya | Received |
7-FXIII | Clinical and Molecular Characteristics of Patients Affected by Congenital Fibrinogen Deficiency | MUNIRA BORHANY | Received |
7-FXI | Procoagulant Activity in Immunoglobulin Products | Stella Williams | Received |
7-FIB | The Time Course of Plasma Procarboxypeptidase U (proCPU, proCPB2 or TAFI) in Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage is Not Associated with the Presence of Acute Coagulopathy | Dorien Leenaerts | Received |
7-PP | Heat Shock Protein 70 (Hsp70) Regulates Platelet Integrin Activation, Granule Secretion and Aggregation | Rachel Rigg | Received |
7-WOM | The Use of TEG/RoTEM in Pregnancy and Pregnancy Associated Complications: Results of a Worldwide Survey by the ISTH SSC for Womens Health Issues In Thrombosis and Haemostasis | Maha Othman | Received |
7-VAS | Gain-of-Function Mutation in TRPV4 Identified in Patients with Osteonecrosis of the Femoral Head | Chantal Seguin | Received |
7-FVIII | Immunological Profile of Previously Untreated Patients with Haemophilia A: Results from the HEMFIL Study | Letícia Lemos Jardim | Received |
7-PLA | Latex-Based Antithrombin Antigen Assays Can Give Falsely Reduced Levels | Peter Cooper | Received |
7-GEN | FVII Deficiency and Thrombosis, Coincidence or New Mechanism of Thrombophilia | Yacine Larfi | Received |
8-FXI | Investigation of Possible Correlation between Clinical and Laboratory Phenotype in Congenital FXI Deficiency: Results from a Single Center | Cristina Santoro | Received |
8-AMC | Hemostatic Disturbances and Oxidative Stress in Experimental Bothrops jararaca Envenomation: Modulation by the Natural Antioxidant Quercetin-3-Rutinoside (Rutin) | Marcelo Santoro | Received |
8-VWF | Platelet type von Willebrand Disease (PT-VWD) Posing Diagnostic and Therapeutic Challenges - Small Case Series | Maha Othman | Received |
8-FVIII | Thrombin Generation Assay (TGA) for Monitoring the Haemostatic Response in Patients with Hemophilia and Inhibitors on Immune Tolerance Induction (ITI): Preliminary in vitro and in vivo Results from the PredicTGA Study | Jordi Bozzo | Received |
8-WOM | Hyperfibrinolysis as One of the Reasons of Recurrent Fetal Loss in the Pregnant Women | Vladimir Sukhaniv | Received |
8-GEN | Identification of Molecular Defects in ITGA2B and ITGB3 Genes and Phenotypic Correlation in Pakistani Patients with Glanzmann Thrombasthenia | Muhammad Younus Jamal Siddiqi | Received |
8-PRE | Prevalence of Hemostatic Defects in Dengue Hemmorhagic Fever in a Tertiary Care Hospital in Karachi | Arshi Naz | Received |
8-FIB | Procarboxypeptidase U (proCPU, TAFI, proCPB2) in Cerebrospinal Fluid (CSF) in the Hyperacute Phase of Ischemic Stroke. | Joachim Mertens | Received |
8-FXIII | Automated Fibrin Structure Assay: Determination of Normal Range | MARTINAUD Christophe | Received |
8-LUP | IgG/IgM Antiphospholipid Antibodies Present in the Classification Criteria of the Antiphospholipid Syndrome: A Critical Review of Their Association with Thrombosis | Hilde Kelchtermans | Received |
8-HEM | Meta-analysis of the risks of arterial and venous occlusive events with new generation BCR-ABL TKIs in patients with chronic myeloid leukemia | Hélène Haguet | Received |
8-PED | The Incidence of Thrombosis and PTS in Children Two Years after Central Venous Catheter Placement | Fiona Newall | Received |
9-VAS | Soluble CD146 Priming Boosts Survival and Regenerative Properties of Endothelial Colony-Forming Cells | Marie Nollet | Received |
9-FIB | Local Hemostasis Changes and Endothelial Damage during Percutaneous Transcatheter Isolation of the Pulmonary Veins in Patients with Atrial Fibrillation | Zsuzsa Bagoly | Received |
9-PED | Body Mass Index is Associated with Symptomatic Venous Thrombotic Events in Pediatric Oncology Patients: A Study from Maritimes, Canada | Ketan Kulkarni | Received |
9-PLA | Estimates of within-subject variation (CVI) of antithrombin, protein C, protein S free and activity, and Activated Protein C resistance (APCR) in pregnant and non-pregnant women. | Ann Helen Kristoffersen | Received |
9-FXIII | Characterization Of Phenotypic And Genotypic Expression Of Inherited Fibrinogen Coagulopathy In Pakistani Index Patients. | Tehmina Nafees Sonia Khan | Received |
9-HEM | Effects of Androgen Deprivation Therapy on Hypercoagulability in Prostate Cancer Patients - A Prospective Longitudinal Study | Maha Othman | Received |
9-PRE | Validation of the ISTH-SSC Bleeding Assessment Tool for the Diagnosis of Inherited Bleeding Disorders: Experience from a Tertiary Care Center in South India | Pagadalu Lokababu Ambika | Received |
9-PP | Risk Factors for Clopidogrel High on-Treatment Platelet Reactivity in Patients with Carotid Artery Stenosis Undergoing Endarterectomy | Dragana Backovic | Received |
9-CA | Prothrombin Conversion and Thrombin Inactivation in Patients Anticoagulated with Enoxaparin, Vitamin K Antagonists, and Rivaroxaban | Romy Kremers | Received |
9-LUP | Detection of Anti-Domain I Beta-2 Glycoprotein I Antibodies by Chemiluminescence Immunoassay in Antiphospholipid Syndrome Diagnosis | Ludek Slavik | Received |
9-VWF | Divergent Clinical and Laboratory Features of Acquired VWF Abnormalities in Patients with Pulmonary Hypertension versus High Shear Cardiac Lesions: Importance of the Procoagulant Property of VWF Multimers | Austin Christopher | Received |
9-WOM | Risk Assessment of Venous Thromboembolism (VTE) and Thromboprophylaxis in Women Hospitalized with Multiple Pregnancy | VENINA BARROS | Received |
10-LUP | Study of Anti-Cardiolipin (IgG/IgM aCL) and Anti-Beta2-Glycoprotein I (anti-2GPI) Antibodies in Patients with Ischemic Stroke (Ouest of Algeria) | KATIA ALLAL | Received |
10-AMC | Acquired von Willebrand Syndrome Evoked by Experimental Bothrops jararaca Envenomation | Marcelo Santoro | Received |
10-PED | Catheter-Related Arterial Thrombosis in Children: A Systematic Review | Mattia Rizzi | Received |
10-VWF | Severe Acquired von Willebrand Syndrome - A Single Centre Experience | Ingrid Hrachovinova | Received |
10-VAS | Activated Protein C (APC) Down Regulates Neutrophil Extracellular Traps (NETs): Potential Contributing Mechanism for Anti-Inflammatory and Antithrombotic Effects Of APC | Laura Healy | Received |
10-WOM | Inherited Thrombophilia Influences Localization and Extent of Pregnancy Related Deep Venous Thrombosis | Jelena Bodrozic | Received |
10-FIB | Thrombin Activatable Fibrinolytic Inhibitor (TAFI) Increases in the Plasma of Cancer Patients with Pro-Thrombotic Behavior | Juan-Carlos Murciano | Received |
10-FVIII | Evaluation of the Efficiency of Immunotolerance in Hemophilia A: Preliminary Results of the Brazilian Immmunotolerance Study | Pedro Henrique Fernandes do Carmo Las Casas | Received |
10-FXIII | Functional/Antigen Fibrinogen Ratio in Different Clinical Situations | Lucia Remotti | Received |
11-PED | Diagnostic Challenges and Clinical Implications in Children with Congenital Bleeding Disorders: A Developing Country Perspective | Sehar Khaliq | Received |
11-FIB | Combinatorial Therapy with C1 Esterase Inhibitor and Tranexamic Acid to Treat Hemorrhagic Shock | Veronika Bade | Received |
11-FXIII | Molecular Modelling of Identified Six Novel Missense Mutations in Pakistani Congenital Afibrinogenemia Patients | Tehmina Nafees Sonia Khan | Received |
11-LUP | Bone Marrow Necrosis and Pulmonary Thrombosis Associated with Antiphospholipid Syndrome | Huseyin Tokgoz | Received |
11-AMC | Patagonfibrase Modifies Protein Expression of Tissue Factor and Protein Disulfide Isomerase in Rat Skin | Marcelo Santoro | Received |
11-PP | Platelets Are Dispensable for Antibody-Mediated Transfusion-Related Acute Lung Injury in the Mouse | Béatrice Hechler | Received |
11-GEN | Identification of Two Novel Single Nucleotide Variants of the Complement Factor H (CFH) and Factor I (CFI) Genes in a Familial Form of Atypical Hemolytic Uremic Syndrome (aHUS) | Célia Dos Santos | Received |
11-CA | Accuracy of the Louzada Prediction Rule for Recurrent VTE in Cancer Patients on Rivaroxaban for the Treatment of Venous Thromboembolic Disease | Melissa Forgie | Received |
11-HEM | Diagnostic Performance of Hemostatic Biomarkers iin Cancer Patients | Elina Beleva | Received |
11-PRE | Inferior Vena Cava (IVC) Filters in Elderly Patients | Amihai Rottenstreich | Received |
11-VAS | Platelet-derived Factor V Is an Important Determinant of Ischemia-mediated Angiogenesis in a Mouse Hindlimb Model | Jianbo Wu | Received |
12-GEN | High Prevalence of VKORC13 (G9041A) Genetic Polymorphism in North Indians: A Study on Patients with Cardiac Disorders on Acenocoumarol | TUSHAR SEHGAL | Received |
12-WOM | Intravenous Iron Therapy in Non-Anemic Iron-Deficient Menstruating Adolescent Females with Fatigue | Ruchika Sharma | Received |
12-FIB | Effect of Elapsed Time between Plasma Separation and Processing on Fibrinolytic Activity | LUCIA REMOTTI | Received |
12-FVIII | ELISA Combined Chromogenic Assay (ECA) for Determination of Binding of PEGylated rFVIII to VWF | Michael Dockal | Received |
12-AMC | Algogenic Compounds Found in Rat Platelet Releasate | Marcelo Santoro | Received |
12-HEM | Evaluation of Thromboelastography (TEG) in Patients with Myeloproliferative Neoplasm (MPN): Platelet Count 600 Associated with Prothrombotic Parameters | Prahlad Ho | Received |
12-VAS | What is the best animal model to specifically target endothelial cells, without concomitant involvement of the hematopoietic lineage? | chloe James | Received |
12-PED | Risk Factors for Hospital-Associated Venous Thromboembolism in Critically-Ill Children with Cardiac Disease Undergoing Cardiothoracic Surgery or Cardiac Catheter-Based Therapeutic Intervention | Christie Atchison | Received |
12-CA | Early Changes in Medication Beliefs, Illness Perceptions and Anticoagulation Related Quality of Life in Patients Poorly Controlled on Vitamin-K Antagonists (VKAs) Switched to a Direct Oral Anticoagulant (DOAC) - Results from the SWITCHING Study | John Abdou | Received |
12-VWF | Functional Characterization of c.4876instgc and c2555ag VWF Gene Variants Identified Type 2 VWD Patient Population in Turkey | ergul berber | Received |
12-PLA | Identification and Significance of Anti-Mpl Autoantibody in Immune Thrombocytopenia | Fangmiao Jing | Received |
13-PED | Risk Factor Assignment Concordance and Clinical Care Guideline Compliance for Prevention of Pediatric Hospital Acquired-Venous Thromboembolism | Brian Branchford | Received |
13-HEM | Cancer, Chronic Kidney Disease and Thrombosis | Nicolas Janus | Received |
13-PP | Myr-RK6 Peptide Selectively Regulates Outside-in Signaling Transduction-Related Functions in Human Platelets | Zhangbiao Long | Received |
13-FIB | Longitudinal Analysis of Coagulant and Fibrinolytic Markers of Trauma Patients that Received Tranexamic Acid | Maria Cristina Bravo | Received |
13-WOM | Thromboelastography in Pregnancy: Establishing Reference Ranges in Third Trimester and Exploring Predictive Value for Postpartum Haemorrhage | Madeleine Malina | Received |
13-FVIII | The Patient Reported Outcome Burdens and Experiences (PROBE) Study - Phase 1 Results Show PROBE Study Methodology Feasible | Mark Skinner | Received |
13-PLA | Decreased miR-142-3p Promotes Survival of Hyperreactive B Cells by Targeting BAFF Receptor in Immune Thrombocytopenia | bin zuo | Received |
13-VWF | Inhibition of a Mouse-Human Chimeric Monoclonal Antibody to von Willebrand Factor on VWF A3-Collagen and VWF A1-Platelet Interactions | Yiming Zhao | Received |
13-CA | Analysis of Heparin Induced Thrombocytopenia Screening Tests in Critical Care Units | Osamah Khojah | Received |
14-VAS | Development of a Platform to Quantify the Colocalization of Neutrophil Extracellular DNA and Coagulation Factors using Immunofluorescence-Based Microscopy | Tiffany Chu | Received |
14-PP | Regulation of aIIb3 Signalling by the ITIM-Containing Receptor G6b-B | Yotis Senis | Received |
14-PRE | Ten Years of Cerebral Venous Thrombosis (CVT) in Northeast Melbourne, Australia: Male Gender and Presence of Myeloproliferative Neoplasm is Associated with Thrombotic Recurrence in Unprovoked Events | Prahlad Ho | Received |
14-CA | Post Analytical External Quality Assessment (EQA) for Computerised Decision Support Software (CDSS) Employed for INR Dosing | Dianne Kitchen | Received |
14-WOM | Screening of Female Family Members of von Willebrand Disease Patients: Utility of a Screening Tool | Claire Philipp | Received |
14-AMC | Aminoestrogen Diebud Decreases Circulating Microparticles | Mirthala Flores | Received |
14-PLA | The Outcome of Eltrombopag Therapy in Immune Thrombocytopenia: A Multicenter Study from Turkey | Gulsum Emel Pamuk | Received |
14-FVIII | The Relationship between Thrombin Generation and Spontaneous Bleeding for Hemophilia a Subjects in A-LONG and Extension Study | Yang Buyue | Received |
14-HEM | Thromboprophylaxis for Prevention of Venous Thromboembolism in Patients with Multiple Myeloma - A Systematic Review and Metaanalysis | Deepa Suryanarayan | Received |
14-VWF | Monoclonal Antibody that Binds to the C-Terminus of the A2 Domain of von Willebrand Factor Effectively Inhibits Platelet Adhesion to Collagen in a Force-Dependent Manner | Miguel Cruz | Received |
15-HEM | Risk Assessment of Venous Thromboembolism (VTE) and Thromboprophylaxis in Pregnant Women Hospitalized with Cancer | VENINA BARROS | Received |
15-VAS | Platelet Function and Microparticles Levels for Patients with Paroxysmal and Persistent Atrial Fibrillation Including during Acute Episodes | Line Pourtau | Received |
15-WOM | Coagulation Factor Changes during Pregnancy in Women with Inherited Bleeding Disorders | Angela Pereira | Received |
15-PP | ABO(H) Blood Group Expression Modifies Platelet Function | Eimear Dunne | Received |
15-VWF | Immunohistochemical Analysis of von Willebrand Factor Biodistribution in Liver Endothelial Cells | Laura Swystun | Received |
15-PRE | Performance of the STA-Liatest D-DI Plus for the Exclusion of Pulmonary Embolism in Emergency Departments using an Age-Adjusted Cut-Off | Laetitia Mauge | Received |
15-CA | External Quality Assurance Provision (EQA) for the Point of Care Xprecia Stride INR Device | Dianne Kitchen | Received |
15-PED | Paediatric Exposure to Intravenous Unfractionated Heparin | Fiona Newall | Received |
16-PRE | D-Dimer Assay Methods State-of-the Art from External Quality Assessment Results | Chantal Bon | Received |
16-CA | An Ultrasound-based Sensor for Real-time Monitoring of Heparin Anticoagulation Therapy | Jesse Jokerst | Received |
16-PED | Risk Factors Associated with Paediatric Thrombosis: A Five Years Retrospective Analysis in a Tertiary Care Hospital | Anila Rashid | Received |
16-WOM | Effect of Pregnancy on the Course of Immune Thrombocytopenia: A Retrospective Multicenter Study | Gulsum Emel Pamuk | Received |
16-PLA | Platelet Proteomics Profiling in Transfusion Adverse Events | Chaker ALOUI | Received |
16-PP | Fibrin Fibers from Cardiovascular Disease Patients on Aspirin Are More Extensible than Fibers from Healthy Individuals | Martin Guthold | Received |
16-FVIII | HLA Genotyping and Factor VIII Intron 22 Inversion in Children with Severe Haemophilia A: Relation to Factor VIII Inhibitor Development | HELEN PERGANTOU | Received |
17-VWF | Modification of ADAMTS13 Isoforms by Estradiol and Histamine Treatment | Célia Dos Santos | Received |
17-CA | Inclusion of a Heparin Neutralizer in the Plasma Diluent Confers Specificity to the FXa Direct Oral Anticoagulants Rivaroxaban, Apixaban, and Edoxaban in an Anti-Xa Chromogenic Assay | Duy Nguyen | Received |
17-PED | Endovascular Stents in Children | Gabriela Sciuccati | Received |
17-VAS | Biological Reference Materials to Standardize Measurements of Extracellular Vesicles | Pia Siljander | Received |
17-PP | The Impact of CYP2C19 2, 3, CYP4F2 3, Fibrinogen (C-148T) Genotype and Clinical Factors on Antiplatelet Effect during Induction of Ticagrelor and Aspirin Therapy | Vacis Tatarunas | Received |
17-PRE | Impact of Severe ADAMTS-13 Deficiency in Patients with Thrombotic Thrombocytopenic Purpura (TTP) on Recurrences | Laura Russo | Received |
17-PLA | Sensitive and Specific Functional Flow Cytometry Assay for the Rapid Diagnosis of Heparin-induced Thrombocytopenia and Thrombosis (HIT) | Michal Cipok | Received |
18-WOM | Proposed Trial: HYPATIA - A Prospective Randomised Controlled Trial of Hydroxychoroquine versus Placebo during Pregnancy in Women with Antiphospholipid Antibodies | Karen Schreiber | Received |
18-PP | Development and Upscaling of the Purification Process of Snake Venom Antiplatelet Agents | Bat-Erdene Jugder | Received |
18-PRE | Description of a New Prothrombin Gene Variant C20214T | Didier JAMBOU | Received |
18-CA | Influence of Factor VII on INR Determined with Recombinant Human and Tissue-Extract Thromboplastins | Joseph Biedermann | Received |
18-VAS | SIRT1 Deficiency in Endothelial Progenitor Cells Drives Pro-Senescent Microparticles Release through MKK6 Upregulation | Anne-Line CHATEAU | Received |
18-VWF | HemosIL VWF:RCo Werfen: A More Sensitive Reagent Than the Reference Technique for the Detection of Acquired von Willebrand Disease in Thrombocytosis Related to Myeloproliferative Neoplasms | chloe james | Received |
18-HEM | Short- and Long-Term Mortality after Pulmonary Embolism in Patients with and without Cancer | Ghazi Alotaibi | Received |
18-PLA | Comparison Head-to Head of Two Functional Assays in the Assessment of Heparin-Induced Thrombocytopenia | nadine ajzenberg | Received |
19-WOM | First Venous Thromboembolic Episodes in Women with Antithrombin Deficiency often associated with Oral Contraceptives or Pregnancy | Ariela Marshall | Received |
19-CA | The Effect of Dabigatran on Thrombin Generation in vitro | Willemijn Comuth | Received |
19-PRE | Venous Thromboembolism and Variants of FGG, F11 and AB0 in Czech Republic | Jan Kvasnicka | Received |
19-VWF | IMPACT OF PLATELET REACTIVITY ON INDIVIDUAL THROMBIN GENERATION IN PATIENTS WITH TYPE 3 AND TYPE 2 VON WILLEBRAND DISEASE | Timea Szanto | Received |
19-PLA | Improved Regulatory B-Cell in Adult Patients with Chronic Immune Thrombocytopenia Treated with Rapamycin | Lan Dau | Received |
19-HEM | Impedance Platelet Aggregometry for Surveillance of Ibrutinib Therapy in Chronic Lymphocytic Leukaemia | Will Thomas | Received |
19-PED | Prevalence and Characteristics of Epistaxis in Saudi Adolescents | Osamah Khojah | Received |
20-HEM | Platelet Transfusion Practices in Adult Surgical, Haematology and Oncology Patients | Anila Rashid | Received |
20-WOM | Evaluation of Protein C and Protein S Levels in Preeclamptic Women Seen in a Tertiary Institution in the Niger-Delta Region of Nigeria - Any Role in the Development of Preeclampsia? | Helen Okoye | Received |
20-PRE | High Sensitive LOCI Based F 12 Immunoassay for Quantification of Prothrombin Fragment 12 in Human Plasma Samples on the New INNOVANCE BCS LT System | Matthias Ehm | Received |
20-FVIII | Introduction of a Standardised Nijmegen - Bethesda Assay for the Detection and Quantification of FVIII Inhibitors | Tracey Noon | Received |
20-PP | Measurement of Platelet Serotonin Secretion by HPLC-Electrochemical Detection (ED) in a Clinical Hemostasis Laboratory: Sensitive, Specific and Accurate Assay for Diagnosing Platelet Secretion Defects and Heparin-Induced Thrombocytopenia | DIEGO MEZZANO | Received |
20-PLA | Slow Responders to Helicobacter pylori Eradication in Adult Japanese Patients with Immune Thrombocytopenia | Koji Miyazaki | Received |
20-CA | Commutability of Samples Used to Assess Assays for Direct Oral Anticoagulants (DOACS): Data from UK NEQAS for Blood Coagulation Multicentre Studies | Ian Jennings | Received |
21-PRE | Getting the Right Product to the Right Patient - Proposed Platelet Concentrate Screening to Improve Transfusion Outcome | Elisabeth Maurer-Spurej | Received |
21-VWF | Recombinant von Willebrand Factor Kinetics and Ultralarge Multimer Content in Severe von Willebrand Disease Patients | Miranda Chapman | Received |
21-CA | Is the Dilute Russells Viper Venom Time (DRVV-T) a Useful Assay for All Direct Oral Anticoagulants (DOACs)? | Miren Gabilondo | Received |
21-PLA | mTOR Staining in Bone Marrow and Spleen Tissues of Immune Thrombocytopenia Patients is Associated with Shorter Relapse-Free Survival | Gulsum Emel Pamuk | Received |
21-FVIII | Isolation of Antibodies that Differentiate Between Wild-Type FIX and the Padua Variant | Dirk Voelkel | Received |
21-VAS | Circulating Lipoprotein (a) Increases Aortic-Valve Calcification | Roberto Garrido | Received |
22-FVIII | Development and Application of a FIX-Specific Immunoassay to Monitor Hemophilia B Gene Therapy | Dirk Voelkel | Received |
22-WOM | High Factor VIII and Advanced Disease Are Associated with Risk of Recurrent Thrombosis in Women with Breast Cancer | Mirjana Kovac | Received |
22-PED | Frequency of Factor V Leiden and Prothrombin Mutation in Thrombotic Events in Children in North Moravian Region | Tomas Kuhn | Received |
22-HEM | The Hypercoagulable Profile of Patients with Myeloproliferative Neoplasms (MPN) as Detected by Whole Blood Rotational Thromboelastometry (ROTEM) | Cinzia Giaccherini | Received |
22-VWF | Phenotype Analysis Associated to p.Arg1315Cys (p.R1315C); the Value of DDAVP and VWFpp/VWF: Ag Ratio to Reach the Diagnosis | Alicia Blanco | Received |
22-PRE | Evaluation of the Risk Factors of Recurrence of Cerebral Venous Thrombosis | GISELLI SOUZA PIRES | Received |
22-PP22 | Platelet Calcium Flux Measurement by Flow Cytometry in Diluted Whole Blood | Barry Wilbourn | Received |
23-PLA | Can Heparin-Induced Multiple Electrode Aggregometry Improve Heparin-Induced -Thrombocytopenia (HIT) Diagnosis in the Intensive Care Unit Setting? A Prospective Study | Vasiliki Gkalea | Received |
23-CA | Consequences of Warfarin Suspension after Major Bleeding in a Cohort of Very Elderly Patients | Giacomo Zoppellaro | Received |
23-PRE | Does Thrombin Generation Test Predict the Outcome of Ischemic Stroke after Thrombolysis Treatment? | Zsuzsa Bagoly | Received |
23-PP | Role of Platelets in the Spatial Clot Growth Investigated with Reaction-Diffusion in vitro Experimental Mode | Anna Balandona | Received |
23-VWF | A Comparative Evaluation of a New Fully-Automated Assay for von Willebrand Factor Collagen Binding Activity to an Established Method | Francesca Stufano | Received |
23-HEM | Thrombosis in Myeloproliferative Neoplasia Associated with Different Coagulation Factor Polymorphisms | Ruta Dambrauskiene | Received |
24-VAS | Acidic Preconditioning Improves Endothelial Progenitor Cell Survival and Functionality under Inflammatory Conditions | Hebe Agustina Mena | Received |
24-CA | Assessment of Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Results from the TRIVET Study | Wendy Lim | Received |
24-WOM | Multicenter Registry on Thrombophilia and Pregnancy Loss: The OTTILIA Study | Elvira Grandone | Received |
24-PLA | Very Low Incidence of Heparin-Induced Thrombocytopenia in Pediatric Patients, Even in those with a High Pretest Probability | Takuma Maeda | Received |
24-HEM | Evaluation of Mean Platelet Volume as a Predictive Marker for Venous Thromboembolism in Patients Treated for Hodgkin Lymphoma | Joanna Rupa-Matysek | Received |
24-PP24 | Psoralen and Ultraviolet A Light Treatment Inhibits Activation of PI3K Dependent Effector Kinases by Disturbing Cell Membrane Packing | Hendrik Feys | Received |
24-FVIII | Benefit of the Study of F8 Gene Transcription by in vitro, in vivo and in silico Analysis in Hemophilia A | Catherine Costa | Received |
24-VWF | Von Willebrand Factor (VWF) Assays and the Diagnosis of von Willebrand Disease (VWD). Who Follows the Guidelines? | Ian Jennings | Received |
25-HEM | Risk Factors Assessment for Thrombosis in Patients with Cancer - Research Project of the Federal University of Minas Gerais | Pedro Henrique Fernandes do Carmo Las Casas | Received |
25-WOM | Management of Pregnancy in Patients with vWD | Vera Geierova | Received |
25-CA | Major Bleeding in Patients with Atrial Fibrillation on Non Vitamin K Antagonist Oral Anticoagulants - Data from Ljubljana Registry | Petra Sinigoj | Received |
25-FVIII | Method-Related Potency Issues of Modified Factor VIII Products | Daniels Sarah | Received |
25-PLA | A Rapid IgG Specific Lateral Flow Immunoassay Demonstrates Superior Diagnostic Performance to Platelet Factor 4/Heparin-Particle Gel Immunoassay in Screening for Heparin-Induced Thrombocytopenia | Noppacharn Uaprasert | Received |
25-VWF | Computer Modeling of Platelet Adhesion to a Surface with Grafted von Willebrand Factor Multimers | Aleksey Belyaev | Received |
26-WOM | The Dependence of Low Molecular Weight Heparin Efficacy (Tested by Anti Xa) on the Level of Antithrombin - A Case Report of a Pregnant Patient with Antithrombin Defficiency | Jana Prochazkova | Received |
26-FVIII | Individualizing Hemophilia Prophylaxis Using Thromboelastography (HIP TEG) | Guy Young | Received |
26-PRE | Sudden Onset Vision Loss as an Initial Manifestation of Elevated Serum Lipoprotein(a) Levels | Umran Caliskan | Received |
26-VWF | Effects of bilirubin on ADAMTS-13 Activity Measured with a FRETS rVWF73 Substrate-Based Fluorescent Assay | Arnaud Bonnefoy | Received |
26-CA | Patients Anticoagulation Knowledge (VKA) and INR Goal Attainment-Comparison 2014 and 2016 | Violeta Jovanoksa | Received |
27-WOM | Yes or No for Anticoagulant Thromboprophylaxis in Pregnant Women with Repeated Pregnancy Loss? | Lucia Stanciakova | Received |
27-PLA | Clinical Significance of Low CD4/CD8 Ratio in Patients with Immune Thrombocytopenic Purpura: A Single Centre Study | Samina Naz Mukry | Received |
27-PP | Functional and Molecular Characterization of an Inherited Abnormal Platelet Function Related to a New CalDAG-GEFI Protein Variant in an Argentinean family | Emilse Bermejo | Received |
27-CA | Can PT, aPTT and TT Reliably Be Used to Detect DOAC at Clinically Relevant Concentrations in Emergency Situations? Results from a 660-Patient Cohort Study | Virginie Siguret | Received |
28-CA | Effectiveness of Implementing an Extended INR Testing Interval for Stable Warfarin Patients: Results from the MAQI2 Collaborative of Anticoagulation Clinics | Geoffrey Barnes | Received |
28-FVIII | Product-Specific Calibration Standards Do Not Correct One-Stage Clotting Assay Discrepancies for Modified Recombinant FIX Molecules with Reagents that Significantly over- or under-Recover Labeled Potency | Yang Buyue | Received |
28-HEM | The Effectiveness of Laboratory Tests in Haemostasis Assessment in Children with Thrombosis with Solid Tumors and Haematologic Malignancies | Natalia Korotina | Received |
28-WOM | The Role of LMWH to Improve the Pregnancy Outcome | Maria Hulikova | Received |
28-VWF | Ferritin Promotes Secretion of von Willebrand Factor (VWF) from Endothelial Cells: a Potential Mechanistic Implication for Patients with Pathological Immune Activation | Dalia Bashir | Received |
28-PLA | An Activating Mutation of DIAPH1 Encoding Rho-Effector Diaphanous-Related Formin-1 Causes Inherited Macrothrombocytopenia Associated with Sensorineural Hearing Loss in a French Family | Paquita Nurden | Received |
29-PP | Value of Whole Blood Impedance Aggregometry in the Diagnosis of Inherited Platelet Function Disorders | Marie Line Moussalli | Received |
29-PLA | Increased Platelet Expression in HIV Positive Treatment Naive Patients Does Not Correlate with CD4 Count | RAEL ONJULA | Received |
29-FVIII | Bleeding Scores in Hemophilia: Are They Useful in Predicting Severity and Clinical Outcomes | MUNIRA BORHANY | Received |
29-VWF | Understanding Normal: Baseline VWF Characteristics in Normal BOECs | Mackenzie Bowman | Received |
29-PRE | Mean Platelet Volume as a Biomarker of Disease Activity in Polymyalgia Rheumatica | Gulsum Emel Pamuk | Received |
30-PP | Diagnostic value of a Flow Cytometry Based Platelet Function Test Compared with Light Transmission Aggregometry in Patients with Unknown Bleeding Disorders | Ivar van Asten | Received |
30-VWF | ADAMTS13 in Chronic Liver Diseases: Data from the Developing World | Priyanka Saxena | Received |
30-CA | Estimation of Rivaroxaban Plasma Concentrations in the Perioperative Setting with or without Heparin Bridging: An Ex vivo Study Using Dedicated Chromogenic Assays | Franois Mullier | Received |
31-CA | Self-testing and Self-management of Oral Anticoagulation Therapy (OAT) in Children with Congenital Heart Disease (CHD). From the Bedside to Home. A Pilot Study in Spain | Veronica Pons | Received |
31-PP | Antiplatelet Aggregation Activity of Two Schiff Base Ligands Derived from 3-Hydroxy-2-Naphthaldehyde and Their Corresponding Copper(II) Complexes | AURORA DE LA PEÑA | Received |
31-FVIII | Thrombin Generation Does Not Correlate with Disease Severity but May Be Predictive of Response to Treatment in Patients with Severe Hemophilia A | Ruchika Sharma | Received |
31-VWF | Bleeding Score in Type 1 von Willebrand vWD Patients using the ISTH-BAT Questionnaire | ANIL PATHARE | Received |
32-PRE | Red Cell Distribution Width is Associated with Atherosclerotic Cardiovascular Mortality in Gouty Arthritis | Gulsum Emel Pamuk | Received |
32-PP | TPO agonist for the Treatment of May Hegglin Anomaly Deriving from MYH9 Mutation | Nadia SARI HASSOUN | Received |
32-FVIII | Prophylaxis with Factor-Eight-Inhibitor-by-Passing-Activity Three Days a Week Results in Safe and Effective Haemostasis in Children with Haemophilia A with Inhibitors | Mark Belletrutti | Received |
32-VWF | Correlation of Phenotypic and Genotypic Expression of VWD Type I and II in Pakistani Patients | SHARIQ AHMED | Received |
33-FVIII | Results from a World-Wide Field Study of FVIII Activity Assay Variability of BAX 855, the PEGlylated form of rFVIII ADVATE, in Clinical Hemostasis Laboratories | peter Turecek | Received |
33-PP | In vitro Antiplatelet Activity of Anthocyanin | Almottesembellah Gaiz | Received |
33-VWF | Comparison between VWF:RCo and VWF:CB in a 2B VWD Cohort | Adriana Woods | Received |
34-PP | Sticky Platelet Syndrome - Questionable or Independent Risk Factor for Thrombosis? | Jan Stasko | Received |
34-VWF | False Negative and False Positive Responses in Ristocetin-Induced Platelet Aggregation Mixing Studies | Juan Pablo Frontroth | Received |
34-CA | Evaluation of the CP3000 Coagulation Analyzer | An Stroobants | Received |
35-PP | An Atypical IgM Antibody that Induces Integrin aIIb3 Activation and Glanzmann Thrombasthenia-Like Phenotype Associated with Macrothrombocytopenia | ZERYAEHY EARHYAETH | Received |
35-FVIII | Multi-National Survey of FVIII Activity Assay Practice | peter Turecek | Received |
35-CA | Evaluation of the Intra-, Inter- and Day-to Day Variability of the ROTEM | Petra Jilma-Stohlawetz | Received |
36-PP | Membrane Microvesicles Generated in Stored Blood Components | EMMANUEL HERNANDEZ | Received |
36-FVIII | Effects of Haemolysis, Icterus and Lipaemia on Coagulation Tests as Performed Using Mechanical Viscosity Based Endpoint Detection | Anita Woolley | Received |
38-CA | A Performance Evaluation of a Novel Human Recombinant Tissue Factor Prothrombin Time Reagent | Chris Gardiner | Received |
38-PP | Aspirin Response in Myeloproliferative Patients using Multiplate Aggregometry | Bethan Myers | Received |
39-PP | Influence of Exercise Intensity on Platelet Aggregation in Patients with Heart Disease. | Hitoshi Adachi | Received |
39-FVIII | Diagnosis and Management of Acquired Haemophilia - Single Centre Experience | Peter Salaj | Received |
39-CA | The Control of Heparin Treatment with Global Hemostasis Assays: A Sensitivity Analysis | Anna Balandona | Received |
40-CA | Evaluation of Laboratoricaly Monitored Efficiency of New Oral Anticoagulants Rivaroksaban and Dabigatran | Marija ega | Received |
40-PP | Platelet Function Diorders Diagnosis Using Flow Cytometry: About 19 Families in Algeria | BOUKERB HOUDA | Received |
40-FVIII | Turkish Experience with Low Dose of Immun Tolerance Treatment for Inhibitor Patients | KAAN KAVAKLI | Received |
41-PP | Predictors of the Secondary Aspirin Resistance in Patients with Coronary Artery Disease over 60 (according to the 10-year follow-up) | Viktoriia Zharinova | Received |
42-CA | Distinct Effects of Apixaban and Rivaroxaban on Thrombin Generation and Coagulation during Recovery after Total Hip Arthroplasty | Tuukka Helin | Received |
42-FVIII | Haemophilia A and Immune Tolerance Induction - Our First Experiences | Marian Fedor | Received |
43-CA | Performance of a New Chromogenic Apixaban Assay on Automated Analyzers | Zhenghua Cao | Received |
44-FVIII | Factor VIII Effect and Sensitivity Vary Depending on Trigger in Thrombin Generation Assays with Plasma from Patients with Hemophilia A | Michael Dockal | Received |
44-CA | Safety and Efficacy of Dabigatran Compared with Warfarin in Patients with Acute Venous Thromboembolism Enrolled in RE-COVER/ RE-COVER II in Western Europe | Michelle Souter | Received |
45-CA | Efficacy and Safety of Dabigatran versus Warfarin for the Treatment of Acute Venous Thromboembolism: a Pooled Analysis of 90-Day Data from RE-COVER and RE-COVER II | Michelle Souter | Received |
46-CA | Application of Basic and Special Coagulation Tests for Measuring Rivaroxaban Activity | Aránzazu García Raso | Received |
46-FVIII | A Simple Predictive Model of Thrombin Generation for the Individualization of Hemophilic Treatment | Pierre Chelle | Received |
47-FVIII | Effectiveness of Heat Inactivation in Removing Residual FVIII Interference in the FVIII Nijmegen Bethesda Assay | Mary Robinson | Received |
48-CA | Reasons and consequences of Vitamin K Antagonists (VKA) Discontinuation in Very Elderly Patients with Non Valvular Atrial Fibrillation (NVAF). An Inception Cohort Study | Giacomo Zoppellaro | Received |
48-FVIII | Haemolysis Effects on Clotting Factor and Thrombotic Assay Results using Matched Haemolysed and Non-Haemolysed Patient Samples and Two Artificial Haemolysis Mechanisms | Paula Brown | Received |
49-FVIII | Application of Rox Factor IX on the ACL TOP 700 | Pia Bryngelhed | Received |
49-CA | The Frequency of Gene Polymorphism among Patients with Hemorrhagic Complications Connected with Warfarin Therapy | Olga Philippova | Received |
50-CA | Prescribing Errors with New Oral Anticoagulants at a Regional Base Hospital in NSW, Australia | David Glendinning | Received |
50-FVIII | The Utility of ISTH BAT in Assessing the Bleeding Phenotype in Patients with FV Deficiency | MUNIRA BORHANY | Received |
52-FVIII | Application of Global Coagulation Assays in Hemophilia B Patients to Evaluate the Hemostatic Potential in Baseline Conditions and after FIX Concentrate Administration | Cristina Santoro | Received |
52-CA | Warfarin as a New Oral Anticoagulant Agent? | Pall Onundarson | Received |
53-FVIII | The Development of Arterial Thrombosis in Hemophilia A - Unusual Coincidence ? Case Report and Review of the Literature | Lucia Stanciakova | Received |
54-CA | Matrix Effect of Commercially Available Direct Oral Anticoagulant Standards: A Look through the Limits and the Need for Standardization of Current Calibrators | Jonathan Douxfils | Received |
54-FVIII | Managing Hemophilia Treatment in Algeria, the Experience of Constantine | SIHEM KEBAILI | Received |
55-FVIII | Epidemiological Study of Hemophilia at Tlemcen University Hospital (Algeria) | BERBER BAHYA | Received |
56-FVIII | Potency Estimates for Recombinant Factor IX in the One-Stage Clotting Assay Are Influenced by More than Just Choice of APTT Reagent | Helen Wilmot | Received |
56-CA | Acute Ischemic Stroke after Administration of Kcentra for Apixaban-associated Intracranial Hemorrhage | Navdeep Lail | Received |
57-CA | Unusual Site Thrombosis - Epidemiology and Outcome | PRAVAS CHANDRA MISHRA | Received |
58-FVIII | Inherited Bleeding Disorders: An Experience from a Tertiary Care Centre in South India with Emphasis on an Algorithmic Approach to Diagnosis | Rakhee Kar | Received |
58-CA | A Comparative Study Using Four Different Clot Detection Methods for INR Monitoring in Patients on Vitamin K Antagonist Treatment | Alex Gatt | Received |
59-CA | Warfarin Dose Assessment Every 4 Weeks versus Every 6 to 8 Weeks in Patients with Stable International Normalized Ratios: A Retrospective Study | Siavash Piran | Received |
59-FVIII | A New Comprehensive Screening Program for Optimizing the Diagnosis of Coagulopathies in a Tertiary Hospital | VERONICA PONS | Received |
60-CA | Development of an INRRIVA on Plasma Samples of Patients on Rivaroxaban | James Zhang | Received |
61-FVIII | Distraction Arthroplasty in Patient with Hemophilic Arthropathy (A Case Report) | Maria Hulikova | Received |
62-CA | A Different Clinical Profile of DOAC-Treated Patients: Results from the Real Life Cohort Study | Miren Gabilondo | Received |
63-CA | Rivaroxaban Therapy for Patients with Pulmonary Embolism in Real World: A Prospective, Single Center, Open-label Observation Study | Tian-Yu Lian | Received |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|